
View larger version (100K):
[in a new window]
|
Fig. 2. E2F mobility-shift assays of nuclear extracts from synchronized
G1 and TGF-ß1-induced preapoptotic cells. Nuclear extracts
were prepared, incubated with wild-type 32P-labeled E2F
oligonucleotide probe and analyzed by PAGE (lanes 1-12) as described in
Materials and Methods. Unlabeled wild-type E2F oligonucleotides were added at
10-fold (lanes 5,9), 100-fold (lanes 6,10) and 1000-fold (lanes 7,11) molar
excess, or a 1000-fold molar excess of unlabeled mutant E2F oligonucleotide
(lanes 8,12) during the 30 minute incubation for binding specificity. Negative
controls containing no nuclear extracts were devoid of activity (lanes 13,14).
The position and numerical designation of the 32P-labeled
DNAprotein complexes are indicated on the left. The
cell-cycle-associated phases of the nuclear extracts are indicated at the top.
mt, mutant E2F oligonucleotide; TGF-ß1, preapoptotic nuclear extract from
HuH-7 cells incubated with TGF-ß1 for 72 hours; wt, wild-type E2F
oligonucleotide.
|